Joseph Ruiz, Ph.D.
Dr. Joseph Ruiz has over 30 years of experience as an investigator in academia and industry in embryonic and adult stem cell biology, genome engineering, hepatic cell biology, cell transplantation, and histotechnology. He has served as a reviewer for National Institutes of Health (NIH) SBIR/STTR applications and currently chairs a Scientific Review Group. Dr. Ruiz’s background of holding positions in both academia and the biotech industry has given him a unique perspective on the importance of developing a comprehensive research plan while also driving research toward clinical or commercial applications. He has held faculty positions at the Indiana School of Medicine and at the Wistar Institute, and has experience directing scientific development at several biotech startup companies, for which he has received millions of dollars in NIH SBIR/STTR funding. In his current role, Dr. Ruiz enjoys advising companies on the best strategies to move their technologies closer to commercialization.
- Biotechnology
- Chemistry
- Diagnostics/Assays
- Energy/Environment
- Pharmaceutical Sciences
- Software/IT
- Scientific Consultant, Eva Garland Consulting
- President, Enzerna Biosciences Inc.
- Adjunct Faculty, Department of Biology, University of Carolina at Chapel Hill
- President and Principal Consultant, Emerging Biotechnology Development Services LLC
- Vice President of Research, Transposagen Biopharmaceuticals
- Director of Research and Development, Vesta Therapeutics
- Assistant Professor, Indiana University School of Medicine
- Assistant Professor, The Wistar Institute
- Postdoctoral Research Assistant, Harvard University
- Postdoctoral Research Assistant, Columbia University
- B.S. in Microbiology from Michigan State
- Ph.D. in Biology from University of California, San Diego